Delivery Order SPE2DB22D2206-SPE2DB23FKL26
Award Date 9/20/23
Potential Completion Date 9/21/23
Potential Value $1.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,466.49 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/ml Emgality pens. The order is to supply the pharmaceutical product to a Defense Logistics Agency location in Conshohocken, Pennsylvania by September 25, 2023. Amerisourcebergen will perform as the prime contractor, with the Defense Logistics Agency as the funding agency. The delivery order was issued under an existing DLA pharmaceutical supply vehicle and does not...
- The Defense Logistics Agency awarded a $2,065.36 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/ml Emgality pens. The order is to be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania by August 15, 2023 in support of DLA programs. Emgality is a medication used to treat conditions such as migraine and cluster headaches. Amerisourcebergen will deliver the requested pharmaceutical products as the prime contractor, with no...
- The Defense Logistics Agency awarded a $2,555.11 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 MG/ML Emgality pens. The order is to be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania by June 27, 2023 in support of the Defense Logistics Agency's medical supply needs. Emgality is a medication used to treat conditions such as migraine and cluster headaches. No set aside designation or subcontractors were identified. The...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $834 to Amerisourcebergen Drug Corporation. The order is for 120 mg/ml Emgality pens and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day in August 2023. Emgality is used to treat conditions such as migraine and cluster headache. This order was issued under an existing DLA contract vehicle but details of the vehicle were not provided....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,233.30 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors, with an ultimate completion date of November 26, 2025. This non-competitive, firm fixed-price delivery order was issued on November 25, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Emgality is a CGRP monoclonal antibody used for migraine prevention, representing a specialized pharmaceutical product within...
- The Defense Logistics Agency awarded a $436 delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania for delivery by September 26, 2023 in support of the Defense Department's medical supply needs. Amerisourcebergen will provide the migraine treatment pens as the prime contractor under an unspecified multiple award contract vehicle with DLA. No set aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,990.63 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the...
- The Defense Logistics Agency (DLA) awarded a $1,506.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors on December 11, 2025, with an ultimate completion date of December 12, 2025. This is a non-set-aside competitive award issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Emgality 120 mg/ml pen injectors, with a ceiling value of $1,527.12. This is a firm fixed price delivery order with an ultimate completion date of September 30, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $417.27 to Amerisourcebergen Drug Corporation. The order is for 120 mg/ml Emgality pens and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 23, 2023. Emgality is a medication used to treat conditions such as migraine and cluster headache. The Defense Logistics Agency leverages contracts such as this to efficiently procure pharmaceuticals and other medical supplies for...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FKL26Delivery Order
The Defense Logistics Agency awarded a $1,112.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/ml Emgality pens. The order is to provide the medication to support DLA's medical supply needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over one day in September 2023. No set aside designation or subcontractors were indicated. This order was issued under an existing DLA medical supply vehicle to fulfill requirements for Emgality, a monoclonal antibody used to treat conditions like migraine and cluster headache.
Generated 12/20/23, 10:14 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/20/23 |